九游会j9

About Us

Company Profile Vision & Culture Core Team Technology Platform Partner Honor Contact Us

Product

Lung Cancer Colorectal Cancer Breast Cancer Gastrointestinal Stromal Tumor Solid Tumor

News

Company News Industry Dynamic

Patient Area

Common Problem Leave a Message Report Download

Join Us

Social Recruitment Campus Recruitment Staff Presence

Search

行业动态

Industry Dynamic

locations： Home News Industry Dynamic

国内首个免疫肿瘤治疗药物纳武单抗（Opdivo®）获CFDA批准
2018年 6月15日 - 百时美施贵宝今日宣布，国家药品监督管理局已正式批准欧狄沃TM（纳武利尤单抗注射液，Nivolumab injection）用于治疗表皮生长因子受体（EGFR）基因突变阴性和间变性淋巴瘤激酶（ALK）阴性、既往接受过含铂方案化疗后疾病进展或不可耐受的局部晚期或转移性非小细胞肺癌（NSCLC）成人患者。

06-21

more +
2018 ASCO全体大会 | KEYNOTE-042研究：pembro脱颖而出，PD-L1低表达OS获益同样显著
2018年6月1日-5日，一年一度的美国临床肿瘤学会（American Society of Clinical Oncology，ASCO）在芝加哥举行。ASCO最瞩目的4项研究终于在当地时间6月3日的全体大会上揭开面纱，下面是LBA4的内容。

06-06

more +

Prev 1 2 3 4 Next

Load More>>

contact us

Tel：020-89637615

Address：Unit C101, No. 9, Spiral 4th Road, Guangzhou International Biological Island

Email：market@zjxinbang.com

About Us Company Profile Vision & Culture Development Core Team Technology Platform
Partner Honor Contact Us
Product Lung Cancer Colorectal Cancer Breast Cancer Gastrointestinal Stromal Tumor Solid Tumor
News Company News Industry Dynamic
Patient Area Common Problem Leave a Message Report Download
Join Us Social Recruitment Campus Recruitment Staff Presence

九游会j9